Skip to main content
Elanco Logo

Vira Shield®

Vira Shield®

As a research-proven, safe and powerful line of inactivated vaccines, Vira Shield® provides comprehensive protection against up to 11 respiratory and reproductive pathogens. Plus, research has shown that Vira Shield allows cows to have improved reproductive performance.¹ Which means you can stress less knowing your herd will be protected and can maintain production.

Key Benefits:

  • Stress less about conception rates with a 6.5% higher first-service conception rate compared to a competitive modified-live virus vaccine1
  • Stress less about disease with comprehensive protection against up to 11 respiratory and reproductive pathogens
  • Safe for both open and pregnant cows despite previous vaccine history.


Stress Less

Where does peace of mind come from? From knowing your cows are protected against up to 11 respiratory and reproductive pathogens. 


Vira Shield 6+VL5 HB

Triangle® 10 HB

Cattle Master GOLD® FP® 5 L5

Comprehensive
No. of antigens available

11

11

10

Respiratory Coverage
Effective against the following pathogens:




BVD Type 1

K

K

K

BVD Type 2

K

K

K

IBR

K

K

MLV

P13

K

K

MLV

BRSV

K

K

MLV

Reproductive Coverage
Effective against the following pathogens:




Leptospira (5-way including L. hardjo-bovis)

C. (Vibrio) fetus



K = Killed Virus, MLV = Modified Live Virus

From Injection To Antigen

Learn about the science behind Vira Shield that activates the acquired immune response. Vira Shield produces strong humoral immunity, and research shows that Vira Shield also creates cell-mediated immunity.3

To learn more about how Vira Shield delivers control without complication, contact your herd health veterinarian or Elanco representative. To find a representative, please call 1‑800‑265‑5475.

Important Information

Learn about Vira Shield indications, directions and safety precautions.

Indications

For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from noncytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

The duration of immunity for BVD Type 2 is at least 11 months4 and the duration of immunity for L. hardjo-bovis is at least 12 months2. Vira Shield has been shown to provide protection from IBR abortions up to 8 months post vaccination5.

For more information regarding efficacy and safety data, click here

For all vaccine products: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.

About Elanco

Learn why we’re a leading provider of innovative solutions that protect and enhance animal health.

Connect with Elanco

Vira Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. All other product and company names are trademarks of their respective owners. PM-CA-25-0271

©2025 Elanco.